ISPOR 19TH ANNUAL EUROPEAN CONGRESS FOCUSES ON EMERGING US VALUE FRAMEWORKS

Published Nov 1, 2016
Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel this afternoon entitled, Emerging US Value Frameworks: Are There Lessons From – Or For – Europe? The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.  The issue panel was moderated by Richard J. Willke, PhD, Chief Science Officer, ISPOR, Lawrenceville, NJ, USA. Speakers for the session included:
  • Peter J. Neumann, ScD, Professor and Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts University, Boston, MA, USA
  • Michael F. Drummond, MCom, DPhil, Professor of Health Economics, Centre for Health Economics, University of York, Heslington, York, UK
  • Finn Børlum Kristensen, MD, PhD, Professor, University of Southern Denmark, Hilleroed, Denmark
ISPOR is spearheading the Initiative on US Value Assessment Frameworks to inform the shift towards a value-driven health care system in the US by promoting the development and dissemination of high-quality, unbiased value assessment frameworks. A Special Task Force has been convened as part of the Initiative that will collaborate to produce a white paper that advises on the appropriate definition and use of high-quality value frameworks. This issue panel discussed the methodological issues that have raised concerns about the validity of the current US value frameworks. The panel noted that existing European health technology assessment (HTA) guidelines, such as the EUnetHTA HTA Core Model®, already consider these methodological issues. The panel considered how the ISPOR Special Task Force adapt and potentially improve upon these European value framework approaches in the development of US value frameworks. Information of the ISPOR Initiative on US Value Assessment Frameworks can be found here. Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×